Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone for cannabis withdrawal
NCT03430050Phase 1Completed
- Sponsor
- Medical University of South Carolina
- Start
- Oct 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in cannabis withdrawal comparing Progesterone with Placebo (2 arms). Primary endpoints: Salivary Progesterone at Day 5 and Cannabis Withdrawal Scale at Day 5. Started Oct 2017; status: completed.
02
Drugs
progesterone
03
Conditions
cannabis withdrawal
Beyond the preview
Go deeper on NCT03430050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03430050.